Bridgeway Capital Management, LLC Precision Biosciences Inc Transaction History

Bridgeway Capital Management, LLC

  • $4.44 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023
SELL
$0.52 - $0.91 $39,000 - $68,250
-75,000 Reduced 23.41%
245,400 $130,000
Q1 2023

May 15, 2023
BUY
$0.7 - $1.41 $34,230 - $68,949
48,900 Added 18.01%
320,400 $240,000
Q4 2022

Feb 14, 2023
BUY
$0.97 - $45.0 $48,500 - $2.25 Million
50,000 Added 22.57%
271,500 $323,000
Q3 2022

Nov 14, 2022
BUY
$1.22 - $40.8 $270,230 - $9.04 Million
221,500 New
221,500 $288,000

Others Institutions Holding DTIL

# of Institutions
7
Shares Held
2.56M
Call Options Held
0
Put Options Held
0
View Full List

About PRECISION BIOSCIENCES INC

DTIL Quotes by TradingView
  • Ticker DTIL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 110,818,000
  • Market Cap $539M
  • Description
  • Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing and ex vivo allogeneic CAR T therapies in the United States. It offers ARCUS, a genome editing platform to cure genetic disorders. The company also provides Ex vivo Allogeneic CAR T Immunotherapy, a form of immunotherapy in which T cell, a specific ...
More about DTIL
Track This Portfolio

Track Bridgeway Capital Management, LLC Portfolio

Follow Bridgeway Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgeway Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bridgeway Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email